8-K Announcements
6Material company update
May 14, 2026·SEC
Material company update
May 13, 2026·SEC
Material company update
May 7, 2026·SEC
GP-Act III Acquisition Corp. remains a speculative shell vehicle currently devoid of operational revenue, with its financial health entirely dependent on sponsor-provided capital.
Price trend, volume and key moving averages
Trailing total returns as of 11/8/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Aug 14, 2026 | $0.01 vs — | — vs — |
Benchmark GPAT against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for GP-Act III Acquisition Corp. (GPAT)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $11.06 | $397.47M | 26.98 | — | — | 4.12% | — | |
| $6.68 | $345.2M | -2.13 | -0.2% | -11.82% | -32.65% | — | |
| $10.04 | $486.58M | 4.67 | 13.07% | 30.33% | 30.43% | — | |
| $865.82 | $260.7B | 16.87 | 8.92% | 41.38% | 15.55% | 1.92% | |
| $181.44 | $286.18B | 17.79 | 14.48% | 26.15% | 17.15% | 2.28% | |
| $334.49 | $896.27B | 16.68 | 7.32% | 30.8% | 16.23% | 1.78% |
GP-Act III Acquisition Corp. (GPAT) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
GP-Act III Acquisition Corp. (GPAT) SEC filings — annual & quarterly reports (10-K, 10-Q)
May 14, 2026·SEC
May 13, 2026·SEC
May 7, 2026·SEC
Get notified when GPAT posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
GP-Act III Acquisition Corp. (GPAT) stock FAQ — growth, dividends, profitability & financials explained
Yes. GP-Act III Acquisition Corp. (GPAT) earned $11.1M in net income over the trailing twelve months.
GP-Act III Acquisition Corp. (GPAT) had a return on equity (ROE) of 4.1% in fiscal year 2025. That is below the market's typical 10-15%.
GP-Act III Acquisition Corp. (GPAT) had negative free cash flow of $0.3M over the trailing twelve months.